Tilray Falls as Shares Trail Major U.S. Indexes

Tilray Brands shares fell 2.66% to $4.02 in the latest trading session, underperforming the S&P 500, which lost 0.77%. The Dow fell 0.67%, while the Nasdaq dropped 0.92%.

Over the past month, Tilray shares have declined 10.02%. The Medical sector lost 3.65% over the same period, while the S&P 500 gained 0.96%.

The company is scheduled to report earnings on October 8. Zacks’ consensus estimate calls for quarterly revenue of $264.9 million, up 26.44% from the year-earlier quarter.

For the full fiscal year, Zacks estimates earnings of -$0.42 per share and revenue of $1.1 billion. The estimates represent changes of 61.47% and 19.63%, respectively, from the prior year.

Zacks said its consensus earnings-per-share estimate for Tilray has remained unchanged over the past 30 days. The upcoming report will provide investors with the company’s latest results against those estimates.